Loading …

Five Biotechs Poised to Advance Their Rare Disease Programs in 2020

Published on : January 28, 2020January 28, 2020 Published by : Steven Surdez

Five Biotechs Poised to Advance Their Rare Disease Programs in 2020 On the cusp of rare disease month, we’re checking in with Maryland biotech companies at the forefront of rare [….]

Cerecor Announces $43 Million Deal with AYTU BioScience to Sell Pediatric Portfolio and Advance Towards NDA

Published on : October 14, 2019October 14, 2019 Published by : Chris Frew

Cerecor Announces $43 Million Deal with AYTU BioScience to Sell Pediatric Portfolio and Advance Towards NDA

Why Developing Cures for Rare Disease Isn’t So Rare Anymore

Published on : September 3, 2019September 5, 2019 Published by : Steven Surdez

Why Developing Cures for Rare Disease Isn’t So Rare Anymore These Six Maryland Biotech Companies Are Seeing Success in Targeting Rare Diseases September 3, 2019 Groundbreaking technology and scientific advancements, [….]